SAN DIEGO STATE UNIVERSITY
(Principal Investigator/Laboratory Name)
AEROSOL TRANSMISSIBLE DISEASE
EXPOSURE CONTROL PLAN
The California Occupational Safety and Health Administration (CalOSHA) Aerosol
Transmissible Diseases Standard effective August 5, 2009, applies to all employees who
could as a result of performing their job tasks, come into contact with aerosol
transmissible pathogens. OSHA'S Aerosol Transmissible Disease standard (8 CCR 5199)
protects employees who work in occupations where they are at risk of exposure to
aerosol transmissible pathogens or contact with cases or suspected cases of aerosol
transmissible diseases. San Diego State University’s Aerosol Transmissible Diseases
Exposure Control Plan can be found at the Environmental Health & Safety website
www.bfa.sdsu.edu/ehs/
POLICY
The (Principal Investigator/ Laboratory Name) is committed to providing a safe and
healthful work environment for our entire staff. Our lab’s policy is to establish,
implement, and maintain an effective Exposure Control Plan (ECP) as required by the
Aerosol Transmissible Diseases Standard in the California Code of Regulations, Title 8 (8
CCR), Section 5199. In pursuit of this goal, the following Exposure Control Plan is
provided to eliminate or minimize occupational exposure to aerosol transmissible
pathogens in accordance with 8 CCR 5199. The plan is consistent with the requirements
of the Cal/OHSA Injury and Illness Prevention Program (8 CCR 3203).
EXPOSURE CONTROL PLAN
This Aerosol Transmissible Diseases ECP is a key document to assist (Principal
Investigator/ Laboratory Name) in implementing and ensuring compliance with the
standard, thereby protecting our employees. This ECP is made available upon request, for
examination and copying, to employees, Chief of Cal/OSHA, and NIOSH (or their
respective designees) in accordance with 8 CCR 3204, “Access to Employee Exposure and
Medical Records”. This ECP includes:


1
Determination of employee exposure
Implementation method and schedule for each of exposure control:
 Methods of Compliance
 Universal precautions
 Engineering and work practice controls
 Personal protective equipment
 Respiratory Protection
 Housekeeping
 Laundry
 Labels
 Vaccinations
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY

 Post-exposure evaluation and follow-up
 Communication of hazards to employees
 Recordkeeping
Effective Procedures for:
 Evaluating circumstances surrounding exposure incidents
 Gathering Supervisor Injury Report and Incident/Accident Report Form
information
 Making periodic determinations of the procedures or equipment that
generate aerosols involved in the exposure incident documented in the
Supervisor Injury Report and/or Incident/Accident Report Form.
 Identifying and selecting appropriate and currently available engineering
control devices for aerosolizing procedures performed by the employees in
their respective work areas or departments.
 Documenting patient safety determination (if applicable)
 Actively involving employees in reviewing and updating the exposure
control plan for the procedures performed by employees in their respective
work areas or departments.
The information-gathering and documentation procedures serve as a basis for making
decisions about the use of aerosolizing procedures and aerosol transmissible pathogens.
Implementation methods and procedures of the elements of the Aerosol Transmissible
Diseases standard are discussed in the subsequent pages of this Exposure Control Plan.
PROGRAM ADMINISTRATION
2

(Name of responsible person or laboratory) is (are) responsible for
developing and implementing this ECP. (Name of responsible person or
laboratory) is (are) responsible for maintaining, reviewing, and updating the ECP
at least annually or more frequently if necessary to reflect any new regulatory
changes, new or modified tasks and procedures that affect occupational exposure,
or changes in technology that eliminate or reduce occupational exposure; to
include new or revised employee positions with occupational exposure; to review
and evaluate the exposure incidents which occurred since the previous updates;
and to review and respond to information indicating that the ECP is deficient in
any area. Contact information: __________.

(Name of responsible person or laboratory) is (are) responsible for making
the exposure determinations. (Name of responsible person or laboratory) is
(are) responsible for maintaining, reviewing, and updating the employee exposure
determination at least annually, and whenever necessary to include new or
modified job title, tasks and procedures. Contact information: __________.

Those employees who are determined to have occupational exposure to aerosol
transmissible pathogens or contact with cases or suspected cases of aerosol
transmissible diseases are responsible for complying with the requirements
outlined in this ECP.
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY

Employees covered by the aerosol transmissible diseases standard will receive an
explanation of this ECP during their initial aerosol transmissible diseases training
session provided by the laboratory. It will also be reviewed in their annual
refresher training. All employees can review this plan at any time during their
work shifts by contacting (Name of responsible person or laboratory). If
requested, the employee will be provided a copy of this ECP free of charge within
15 days of the request. Contact information: __________.

(Name of responsible person or laboratory) is (are) responsible for soliciting
input from non-managerial employees responsible for work with aerosol
transmissible pathogens with aerosolizing procedures or equipment, or direct
patient contact with known or suspected cases of aerosol transmissible diseases in
the identification, evaluation, and selection of effective engineering and work
practice controls, and shall document the solicitation in the ECP.

(Name of responsible person or laboratory) is (are) responsible for providing
and maintaining all necessary personal protective equipment (PPE), engineering
controls (e.g., biosafety cabinet), labels, and red bags as required by the
standard. (Name of responsible person or laboratory) is (are) responsible for
ensuring that adequate supplies of the aforementioned equipment are available in
the appropriate sizes. Contact location/phone number: __________.

(Name of responsible person or laboratory) is (are) responsible for training,
documenting training, and making this written ECP available to employees, OSHA,
and NIOSH representatives. Contact information: __________.

San Diego State University, Environmental Health and Safety Department and
Center for Human Resources will be responsible for ensuring that all medical
actions required by the standard are performed and that appropriate employee
health and OSHA records are maintained. Contact phone number: (x42865).
EMPLOYEE EXPOSURE DETERMINATION
Employees in our department/lab have occupational exposure to aerosol transmissible
pathogens. Occupational exposure means exposure from work activity or working
conditions that is reasonably anticipated to create an elevated risk of contracting any
disease caused by ATPs or ATPs-L if protective measures are not in place. A biohazardous
agent is defined as an aerosol transmissible pathogens - laboratory (ATP-L) if it
meets one of the following criteria: (1) the pathogen appears on the list below, (2) the
Biosafety in Microbiological and Biomedical Laboratories (BMBL) recommends biosafety
level 3 or above for the pathogen, (3) the biological safety officer recommends biosafety
level 3 or above for the pathogen, or (4) the pathogen is a novel or unknown pathogen.
This is a list of agents that, when reasonably anticipated to be present, require a
laboratory to comply with Section 5199 for laboratory operations. (Check all that
Apply)
Adenovirus (in clinical specimens and in cultures or other materials derived from
clinical specimens)
Arboviruses, unless identified individually elsewhere in this list (large quantities or
high concentrations* of arboviruses for which CDC recommends BSL-2,
e.g., dengue virus; potentially infectious clinical materials, infected tissue
3
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY
cultures, animals, or arthropods involving arboviruses for which CDC
recommends BSL-3 or higher, e.g., Japanese encephalitis, West Nile virus,
Yellow Fever)
Arenaviruses (large quantities or high concentrations of arenaviruses for which CDC
recommends BSL-2, e.g., Pichinde virus; potentially infectious clinical
materials, infected tissue cultures, animals, or arthropods involving
arenaviruses for which CDC recommends BSL-3 or higher, e.g., Flexal
virus)
Bacillus anthracis (activities with high potential for aerosol production**, large
quantities or high concentrations, screening environmental samples from
b. anthracis -contaminated locations)
Blastomyces dermatitidis (sporulating mold-form cultures, processing
environmental materials known or likely to contain infectious conidia)
Bordetella pertussis (aerosol generation, or large quantities or high concentrations)
Brucella abortus, B. canis, B. “maris", B. melitensis, B. suis (cultures, experimental
animal studies, products of conception containing or believed to contain
pathogenic Brucella spp.)
Burkholderia mallei, B. pseudomallei (potential for aerosol or droplet exposure,
handling infected animals, large quantities or high concentrations)
Cercopithecine herpesvirus (see Herpesvirus simiae)
Chlamydia pneumoniae (activities with high potential for droplet or aerosol
production, large quantities or high concentrations)
Chlamydia psittaci (activities with high potential for droplet or aerosol production,
large quantities or high concentrations, non-avian strains, infected caged
birds, necropsy of infected birds and diagnostic examination of tissues or
cultures known to contain or be potentially infected with C. psittaci strains
of avian origin)
Chlamydia trachomatis (activities with high potential for droplet or aerosol
production, large quantities or high concentrations, cultures of
lymphogranuloma venereum (LGV) serovars, specimens known or likely to
contain C. trachomatis)
Clostridium botulinum (activities with high potential for aerosol or droplet
production, large quantities or high concentrations)
Coccidioides immitis, C. posadasii (sporulating cultures, processing environmental
materials known or likely to contain infectious arthroconidia, experimental
animal studies involving exposure by the intranasal or pulmonary route)
Corynebacterium diphtheriae
Coxiella burnetti (inoculation, incubation, and harvesting of embryonated eggs or
cell cultures; experimental animal studies, animal studies with infected
arthropods, necropsy of infected animals, handling infected tissues)
Crimean-Congo haemorrhagic fever virus
Cytomegalovirus, human (viral production, purification, or concentration)
Eastern equine encephalomyelitis virus (EEEV) (clinical materials, infectious
cultures, infected animals or arthropods)
Ebola virus
Epstein-Barr virus (viral production, purification, or concentration)
Escherichia coli, shiga toxin-producing only (aerosol generation or high splash
potential)
Flexal virus
Francisella tularensis (suspect cultures––including preparatory work for automated
identification systems, experimental animal studies, necropsy of infected
animals, high concentrations of reduced-virulence strains)
Guanarito virus
4
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY
Haemophilus influenzae, type b
Hantaviruses (serum or tissue from potentially infected rodents, potentially infected
tissues, large quantities or high concentrations, cell cultures, experimental
rodent studies)
Helicobacter pylori (homogenizing or vortexing gastric specimens)
Hemorrhagic fever -- specimens from cases thought to be due to dengue or yellow
fever viruses or which originate from areas in which communicable
hemorrhagic fever are reasonably anticipated to be present
Hendra virus
Hepatitis B, C, and D viruses (activities with high potential for droplet or aerosol
generation, large quantities or high concentrations of infectious materials)
Herpes simplex virus 1 and 2
Herpesvirus simiae (B-virus) (consider for any material suspected to contain virus,
mandatory for any material known to contain virus, propagation for
diagnosis, cultures)
Histoplasma capsulatum (sporulating mold-form cultures, propagating
environmental materials known or likely to contain infectious conidia)
Human herpesviruses 6A, 6B, 7, and 8 (viral production, purification, or
concentration)
Influenza virus, non-contemporary human (H2N2) strains, 1918 influenza strain,
highly pathogenic avian influenza (HPAI) (large animals infected with 1918
strain and animals infected with HPAI strains in ABSL-3 facilities, loosehoused animals infected with HPAI strains in BSL-3-Ag facilities)
Influenza virus, H5N1 - human, avian
Junin virus
Kyasanur forest disease virus
Lassa fever virus
Legionella pneumophila, other legionella-like agents (aerosol generation, large
quantities or high concentrations)
Lymphocytic choriomeningitis virus (LCMV) (field isolates and clinical materials
from human cases, activities with high potential for aerosol generation,
large quantities or high concentrations, strains lethal to nonhuman
primates, infected transplantable tumors, infected hamsters)
Machupo virus
Marburg virus
Measles virus
Monkeypox virus (experimentally or naturally infected animals)
Mumps virus
Mycobacterium tuberculosis complex (M. africanum, M. bovis, M. caprae, M.
microti, M. pinnipedii, M. tuberculosis (aerosol-generating activities with
clinical specimens, cultures, experimental animal studies with infected
nonhuman primates)
Mycobacteria spp. other than those in the M. tuberculosis complex and M. leprae
(aerosol generation)
Mycoplasma pneumoniae
Neisseria gonorrhoeae (large quantities or high concentrations, consider for aerosol
or droplet generation)
Neisseria meningitidis (activities with high potential for droplet or aerosol
production, large quantities or high concentrations)
Nipah virus
Omsk hemorrhagic fever virus
Parvovirus B19
5
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY
Prions (bovine spongiform encephalopathy prions, only when supported by a risk
assessment)
Rabies virus, and related lyssaviruses (activities with high potential for droplet or
aerosol production, large quantities or high concentrations)
Retroviruses, including Human and Simian Immunodeficiency viruses (HIV and
SIV) (activities with high potential for aerosol or droplet production, large
quantities or high concentrations)
Rickettsia prowazekii, Orientia (Rickettsia) tsutsuagmushi, R. typhi (R. mooseri),
Spotted Fever Group agents (R. akari, R. australis, R. conorii, R.
japonicum, R. rickettsii, and R. siberica) (known or potentially infectious
materials; inoculation, incubation, and harvesting of embryonated eggs or
cell cultures; experimental animal studies with infected arthropods)
Rift valley fever virus (RVFV)
Rubella virus
Sabia virus
Salmonella spp. other than S. typhi (aerosol generation or high splash potential)
Salmonella typhi (activities with significant potential for aerosol generation, large
quantities)
SARS coronavirus (untreated specimens, cell cultures, experimental animal studies)
Shigella spp. (aerosol generation or high splash potential)
Streptococcus spp., group A
Tick-borne encephalitis viruses (Central European tick-borne encephalitis, Far
Eastern tick-borne encephalitis, Russian spring and summer encephalitis)
Vaccinia virus
Varicella zoster virus
Variola major virus (Smallpox virus)
Variola minor virus (Alastrim)
Venezuelan equine encephalitis virus (VEEV) (clinical materials, infectious cultures,
infected animals or arthropods)
West Nile virus (WNV) (dissection of field-collected dead birds, cultures,
experimental animal and vector studies)
Western equine encephalitis virus (WEEV) (clinical materials, infectious cultures,
infected animals or arthropods)
Yersinia pestis (antibiotic resistant strains, activities with high potential for droplet
or aerosol production, large quantities or high concentrations, infected
arthropods, potentially infected animals)
Other:
* ‘Large quantities or high concentrations’ refers to volumes or concentrations considerably in excess of
those typically used for identification and typing activities. A risk assessment must be performed to
determine if the quantity or concentration to be used carries an increased risk, and would therefore
require aerosol control.
** ‘activities with high potential for aerosol generation’ include centrifugation
Our policy is to conduct exposure determinations throughout the facility without regard to
the use of personal protective equipment (PPE). We have committees, workgroups, lead
person, or individuals who conduct evaluate, and periodically review exposure
determinations. This process involves identifying all the job classifications, tasks, or
procedures in which our employees may have occupational exposure to ATP-L. Our
approach is to consider all our job classifications at once. Other methods or procedures
used to conduct exposure determinations include gathering information, making
decisions, and identifying sources from which equipment will be purchased.
6
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY
I.
Examples of job classifications in which all employees have occupational
exposure:
The following is a list of all job classifications at (Principal Investigator/
Laboratory Name) in which all employees in these job classifications have
occupational exposure:
Job Title
Facility Location
(Example: Tb Researcher)
(Building, Room)
(use as many lines as necessary)
II.
Examples of job classification in which some employees have occupational
exposure:
The following is a list of all job classifications in which some employees at (Principal
Investigator/ Laboratory Name) have occupational exposure. The only individuals
who have occupational exposure in the job classification listed below are those who
perform the task/procedures noted below:
Job Title
Facility Location
(Example: Researcher)
(Building, Room)
Task/Procedure
(Tissue Culture)
(use as many lines as necessary)
NOTE: Part-time, temporary, contract and per diem employees are covered by the
aerosol transmissible disease standard. The ECP should describe how the standard will be
met for these employees.
METHODS OF IMPLEMENTATION, COMPLIANCE, AND CONTROL
METHODS OF COMPLIANCE
I.
Universal Precautions
All employees will utilize universal precautions to prevent exposure to known or
suspected cases of aerosol transmissible diseases. All incoming materials
containing ATPs-L are to be treated as containing the virulent or wild-type
pathogen, until procedures have been conducted in this laboratory to verify
that a pathogen has been de-activated or attenuated. (Provide testing
results for de-activation or attenuation)
II.
Engineering and Work Practice Controls – General Requirements


7
Engineering controls and work practice controls will be used to prevent or
minimize exposure to aerosols when working with ATPs-L.
Engineering controls shall be examined and maintained or replaced on a regular
schedule to ensure their effectiveness.
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY


III.
Work practice controls shall be evaluated and updated on a regular schedule to
ensure their effectiveness.
All procedure involving ATPs-L shall be performed in such a manner as to
minimize splashing, spraying, spattering, and generation of droplets of these
substances.
Engineering and Work Practice Controls – Specific Requirements
The specific engineering controls and work practice controls used are listed below and
described in the CalOSHA Safety and Health Fact Sheet:
(Example: sealed/capped tubes, sealed rotors on centrifuges,)
(use as many lines as necessary)

Prohibited Practices






Do not sniff in vitro cultures.
Broken glassware which may be contaminated shall not be picked up directly
with the hands. It shall be cleaned up using mechanical means, such as a
brush and dust pan, tongs, or forceps.
When applying disinfectant to a known spill of ATP-L, never spray directly at
liquid spill. Cover liquid spill with absorbent, then apply the disinfectant to
the absorbent to eliminate aerosolization of ATP-L.
Mouth pipetting/suctioning of cultures is prohibited.
Eating, drinking, smoking, applying cosmetics or lip balm, and handling
contact lenses are prohibited in work areas where there is a reasonable
likelihood of occupational exposure.
Food and drink shall not be kept in refrigerators, freezers, shelves, cabinets or
on countertops or benchtops where APT-L are present.
This facility identifies the need for changes in engineering controls and work practices
through (Examples: Review of OSHA records, employee interviews, committee
activities, etc.)
We evaluate new procedures and new products regularly by (Describe the process,
literature reviewed, supplier info, products considered).
Both front-line workers and management officials are involved in this process in the
following manner: (Describe employees' involvement)
(Name of responsible person or department) is responsible for ensuring that
these recommendations are implemented.
IV.
Personal Protective Equipment (PPE) PPE is provided to our employees at no cost
to them. Training in the use of the appropriate PPE for specific tasks or procedures is
provided by (Name of responsible person or department).
8
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY
The types of PPE available to employees are as follows:
(gloves, eye protection, etc.)
PPE is located (List location) and may be obtained through (Name of responsible
person or department). (Specify how employees will obtain PPE and who is
responsible for ensuring that PPE is available.)
All employees using PPE must observe the following precautions:

Wash hands immediately or as soon as feasible after removing gloves or other
PPE.

Remove PPE after it becomes contaminated and before leaving the work area.

Used PPE may be disposed of in (List appropriate containers for storage,
laundering, decontamination, or disposal.)

Wear appropriate gloves when it is reasonably anticipated that there may be hand
contact with ATPs-L, and when handling or touching contaminated items or
surfaces; replace gloves if torn, punctured or contaminated, or if their ability to
function as a barrier is compromised.

Utility gloves may be decontaminated for reuse if their integrity is not
compromised; discard utility gloves if they show signs of cracking, peeling,
tearing, puncturing, or deterioration.

Never wash or decontaminate disposable gloves for reuse.

Wear appropriate face and eye protection when splashes, sprays, spatters, or
droplets of ATPs-L pose a hazard to the eye, nose, or mouth.

Remove immediately or as soon as feasible any garment contaminated by ATPs-L,
in such a way as to avoid contact with the outer surface.
The procedure for handling used PPE is as follows:
(may refer to specific procedure; include how and where to decontaminate
face shields, eye protection)
IV.
Respiratory Protection
Respirators are an important means of reducing exposure to infectious aerosols.
Air purifying respirators provide a barrier to prevent workers from inhaling ATPs-L
in animal facilities and for procedures that cannot be feasibly conducted in a
Biosafety Cabinet. Only procedures involving ATPs-L that are approved by the
Institutional Biosafety Committee can be conducted outside of a biosafety cabinet
with the use of a respirator.
All employees will complete an a fit-test at the time of initial fitting, whenever a
different size, make, model or style of respirator is used, and whenever you
report a change in physical characteristics that may affect fit, such as major
dental work, facial surgery or injury, or a change in weight.
9
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY
Fit tests must also be repeated periodically, because people are not always aware
of facial changes that may have affected the fit of the respirator. Generally,
Cal/OSHA regulations require that fit-tests be repeated annually. The aerosol
transmissible disease standard permits employers to lengthen this interval to
every two years for employees who are not exposed to high hazard procedures,
such as bronchoscopies.
(Describe any high hazard procedures conducted in the lab outside of a biosafety
cabinet).
(Describe any procedures using ATPs-L and animal models)
Housekeeping Regulated waste is placed in containers which are closable,
constructed to contain all contents and prevent leakage, appropriately labeled or
color-coded (see the following section "Labels"), and closed prior to removal to
prevent spillage or protrusion of contents during handling.
V.
The procedure for handling biohazardous waste disposal containers is: (describe
specific procedure or refer to Biohazardous and Sharps Waste Disposal
Policies and Procedures on EHS Website)
The procedure for handling other regulated waste is: (describe specific procedure
or refer to Hazardous Materials and Hazardous Waste Management Practices
booklet available through EHS)
Contaminated sharps are discarded immediately or as soon as possible in containers
that are closable, puncture-resistant, leak proof on sides and bottoms, and
appropriately labeled and red. Sharps disposal containers are available at (Indicate
location, must be easily accessible and as close as feasible to the immediate
area where sharps are used).
Bins and pails (e.g., wash or emesis basins) are cleaned and decontaminated as soon
as feasible after visible contamination.
Broken glassware that may be contaminated is only picked up using mechanical
means, such as a brush and dustpan.
Laundry The following contaminated articles will be laundered by this company:
VI.
Laundering will be performed by (Name of responsible person or department) at
(time and/or location).
The following laundering requirements must be met:
10

handle contaminated laundry as little as possible, with minimal agitation

place wet contaminated laundry in leak-proof, labeled or color-coded containers
before transport. Use (specify either red bags or bags marked with the biohazard
symbol, or other bag type and labeling based on laundering vendor requirements)
for this purpose.

wear the following PPE when handling and/or sorting contaminated laundry: (List
appropriate PPE).
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY
VII.
Labels The following labeling methods are used in this facility:
Equipment to be Labeled
Label Type (size, color)
(specimens, contaminated laundry, etc.) (red bag, biohazard label)
(Name of responsible person or department) is responsible for ensuring that
warning labels are affixed or red bags are used as required if regulated waste or
contaminated equipment is brought into the facility. Employees are to notify (Name
of responsible person or department) if they discover regulated waste containers,
refrigerators containing ATPs-L, contaminated equipment, etc., without proper labels.
Labels can be obtained through San Diego State University, Environmental Health and
Safety Department at Chemical Sciences Laboratory 106.
VACCINATIONS
San Diego State University, Environmental Health and Safety Department will provide
training to employees on ATP-L vaccinations, addressing safety, benefits, efficacy,
methods of administration, and availability.
(Check with the CDC Advisory Committee on Immunization Records for available
vaccination not included in this list.)
Vaccine
Schedule
Influenza
One dose annually
Measles
Two doses
Mumps
Two doses
Rubella
One dose
Tetanus, Diptheria,
One dose, booster as recommended
Acellular Pertussis (Tdap)
Varicella-zoster (VZV) Two doses
Other:
The above vaccinations are available at no cost after initial employee training and within
10 days of initial assignment to all employees identified in the exposure determination
section of this plan. Vaccination is encouraged unless: 1) documentation exists that the
employee has previously received the series; 2) antibody testing reveals that the
employee is immune; or 3) medical evaluation shows that vaccination is contraindicated.
However, if an employee declines the vaccination, the employee must sign a declination
form. Employees who decline may request and obtain the vaccination at a later date at
no cost. Documentation of refusal of the vaccination is kept at Chemical Sciences
Laboratory 106.
Vaccination will be provided by (List health care professional responsible for this
part of the plan: students – Student Health Services Employees – Sharp Rees
Stealy Occupation Medicine Department) at (location – Calpulli Center or
Grossmon/La Mesa Sharp Rees Stealy).
Following the medical evaluation, a copy of the health care professional's written opinion
will be obtained and provided to the employee within 15 days of the completion of the
11
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY
evaluation. It will be limited to whether the employee requires the vaccine and whether
the vaccine was administered.
POST-EXPOSURE EVALUATION AND FOLLOW-UP
Should an exposure incident occur, contact (Name of responsible person) at the
following number ____________________ .
An immediately available confidential medical evaluation and follow-up will be conducted
by (name of licensed health care professional). Following initial first aid (clean the
wound, flush eyes or other mucous membrane, etc.), the following activities will be
performed:







Document the routes of exposure and how the exposure occurred.
Identify and document the source individual (unless the employer can establish
that identification is infeasible or prohibited by state or local law).
Obtain consent and make arrangements to have the source individual tested as
soon as possible to determine aerosol transmissible pathogen; document that the
source individual's test results were conveyed to the employee's health care
provider.
If the source individual is already known to have an aerosol transmissible disease,
new testing need not be performed.
Assure that the exposed employee is provided with the source individual's test
results and with information about applicable disclosure laws and regulations
concerning the identity and infectious status of the source individual (e.g., laws
protecting confidentiality).
After obtaining consent, collect exposed employee's blood as soon as feasible
after exposure incident, and test blood for aerosol transmissible diseases.
If the employee does not give consent for serological testing during collection of
blood for baseline testing, preserve the baseline blood sample for at least 90
days; if the exposed employee elects to have the baseline sample tested during
this waiting period, perform testing as soon as feasible.
ADMINISTRATION OF POST-EXPOSURE
EVALUATION AND FOLLOW-UP
San Diego State University, Environmental Health and Safety Department ensures that
health care professional(s) responsible for employee's ATP-L vaccinations and postexposure evaluation and follow-up are given a copy of OSHA's aerosol transmissible
diseases standard.
San Diego State University, Environmental Health and Safety Department ensure that the
health care professional evaluating an employee after an exposure incident receives the
following:






12
a description of the employee's job duties relevant to the exposure incident
aerosol transmissible pathogen
route(s) of exposure
circumstances of exposure
if applicable and possible, results of the source individual's blood test
relevant employee medical records, including vaccination status
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY
San Diego State University, Environmental Health and Safety Department provides the
employee with a copy of the evaluating health care professional's written opinion within
15 days after completion of the evaluation.
PROCEDURES FOR EVALUATING THE CIRCUMSTANCES
SURROUNDING AN EXPOSURE INCIDENT
San Diego State University, Environmental Health and Safety Department will review the
circumstances of all exposure incidents to determine:







engineering controls in use at the time
work practices followed
a description of the ATPs-L attenuations or deactivations
protective equipment or clothing that was used at the time of the exposure
incident (gloves, eye shields, etc.)
location of the incident
procedure being performed when the incident occurred
employee's training
If revisions to this ECP are necessary San Diego State University, Environmental Health
and Safety Department will ensure that appropriate changes are made. (Changes may
include an evaluation of engineering controls, adding employees to the exposure
determination list, etc.)
EMPLOYEE TRAINING
All employees who have occupational exposure to ATPs-L receive initial and annual
training conducted by this laboratory.
All employees who have occupational exposure to ATPs-L receive training on the
epidemiology, symptoms, and transmission of the specific ATPs-L in use in the lab. In
addition, the training program covers, at a minimum, the following elements:










13
a copy and explanation of the OSHA aerosol transmissible diseases standard
an explanation of this ECP and how to obtain a copy
an explanation of methods to recognize tasks and other activities that may
involve exposure to ATPs-L, including what constitutes an exposure incident
an explanation of the use and limitations of engineering controls, work practices,
and PPE
an explanation of the types, uses, location, removal, handling, decontamination,
and disposal of PPE
an explanation of the basis for PPE selection
information on available ATPs-L vaccine, including information on its efficacy,
safety, method of administration, the benefits of being vaccinated, and that the
vaccine will be offered free of charge
information on the appropriate actions to take and persons to contact in an
emergency involving ATPs-L
an explanation of the procedure to follow if an exposure incident occurs, including
the method of reporting the incident and the medical follow-up that will be made
available
information on the post-exposure evaluation and follow-up that the employer is
required to provide for the employee following an exposure incident
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY


an explanation of the signs and labels and/or color coding required by the
standard and used at this facility
an opportunity for interactive questions and answers with the person conducting
the training session.
RECORDKEEPING
Training records are completed for each employee upon completion of training. These
documents will be kept for at least three years at (Building and Room of laboratory).
The training records include:




the
the
the
the
dates of the training sessions
contents or a summary of the training sessions
names and qualifications of persons conducting the training
names and job titles of all persons attending the training sessions
Employee training records are provided upon request to the employee or the employee's
authorized representative within 15 working days. Such requests should be addressed to
(Name of responsible person).
Medical Records
Medical records are maintained for each employee with occupational exposure in
accordance with 29 CFR 1910.1020, "Access to Employee Exposure and Medical Records."
San Diego State University, Human Resources Department is responsible for maintenance
of the required medical records. These confidential records are kept in Extended Studies
Center for at least the duration of employment plus 30 years.
Employee medical records are provided upon request of the employee or to anyone
having written consent of the employee within 15 working days. Such requests should be
sent to 5500 Campanile Dr San Diego CA 92182-1625.
OSHA Recordkeeping
An exposure incident is evaluated to determine if the case meets OSHA's Recordkeeping
Requirements (29 CFR 1904). This determination and the recording activities are done by
San Diego State University, Environmental Health and Safety Department.
I have attended laboratory specific safety training for the laboratory specific Aerosol
Transmissible Disease Exposure Control Program. I have read and understood this
Exposure Control Program and I have had my questions answered.
Date
14
Attendee Name (Print)
Signature
Rev. 10/2013
SAN DIEGO STATE UNIVERSITY
15
Rev. 10/2013